Skip to product information
1 of 5


HeadaTerm 2 Migraine Headache Relief Device

HeadaTerm 2 Migraine Headache Relief Device

Regular price $99.99
Regular price $129.99 Sale price $99.99
Sale Sold out
Shipping calculated at checkout.

HeadaTerm 2 is a clinically proven, safe, and effective medical device worn on users’ foreheads that uses none-invasive neuronal electrical stimulation technology to prevent and treat primary headache, including migraine, tension headache, cluster headache.

✅ FDA OTC approved for migraine relief.
✅ Rechargeable for repeated use.
✅ Manual adjustment for personalized stimulation.

View full details
sale up to 30% off

Exclusive Early Bird Price for the HeadaTerm2

Act fast! Only 100 early bird slots available – reserve yours now!

Discount Code: PREHT30


Safety Certification

FDA-approved for safety and effectiveness.


Physical Therapy

Fast-acting relief with eTNS technology and no side effects.



Affordable home medical products.


HSA/FSA Eligible

Vouchers available for reimbursement upon purchase.

Up to 27% more effective than oral medicine

Published by Emergency Medicine in the United States

Learn More



Primary headaches, such as migraine, are transmitted by the supraorbital nerve and the supratrochlear nerve. HeadaTerm introduces precise electric impulses from the user’s forehead to act on these nerves and reduce the migraine signals transmitted. The device avoids any drug effects, making it appropriate a wide range of users.

Three Major Benefits of HeadaTerm 2


Treating Migraine Headaches


Effective in Significantly Relieving Acute Migraine Symptoms


Relieve Migraine


Effective in Reducing Migraine Pain Levels


Prevent Migraine


Effective in Reducing the Incidence of Migraines


For every HeadaTerm 2 Anti-migraine Device purchased, $1 will be donated to The American Legion.

*Donate every 5 months and publish the donation voucher

Learn more


100% secure checkout

30 Days Money Back Guarantee

1-year warranty guarantee

Worldwide Shipping

Fast delivery available

Free Shipping on All Orders Over $30

Multi-country transfer within 5-7 days

PrincipleeTNS technology
IndicationsThe TENS device-HeadaTerm 2 is indicated for the prophylactic treatment of episodic migraine in patients 18 years of age or older.
CertificateFDA, CE, TGA, HC, ISO

Relieve Migraine Without Medication


100% Drug-Free

Easy Operation

Quick Effect

New Generation Of Targeted Thrapeutic Anti-Migraine Device

Primary headaches are debilitating conditions that are extremely common among people. Drug treatments are the popular solutions for many patients, but just like with anti-nausea drugs, there are side effects that often turn people away. HeadaTerm offers a drug-free treatment without any side effects.

More advanced than HeadaTerm Generation 1.


How to use

Learn more

HeadaTerm 2 Electrode (3-pack)


HeadaTerm Official Sustainability Plan

Every 5 used devices can be exchanged for 1 new device.

Learn More

EmeTerm® HeadaTerm Testimonials

Customers Testimonials


  • Hokenek N M, Erdogan M O, Hokenek U D, et al. Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: A randomize controlled trial[J]. The American Journal of Emergency Medicine, 2021, 39: 80-85.
  • Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain. 2003 Apr;4(3):109-21.
  • Shealy CN. Transcutaneous electrical nerve stimulation: the treatment of choice for pain and depression. J Altern Complement Med. 2003 Oct;9(5):619-23.
  • Huang W, Kutner N, Bliwise DL. Autonomic activation in insomnia: the case for acupuncture. J Clin Sleep Med. 2011 Feb 15;7(1):95-102.
  • Kirsch DL, Nichols F. Cranial electrotherapy stimulation for treatment of anxiety, depression, and insomnia. Psychiatr Clin North Am. 2013 Mar;36(1):169-76.
  • Schoenen J, Vandersmissen B, Jeangette S, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013 Feb 19;80(8):697-704.
  • Nihat M. Hokenek, MD. Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: A randomized controlled trial. VOLUME 39, P80-85, JANUARY 01, 2021